Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRNA | Common Stock | Options Exercise | $0 | +703 | $0.00 | 703 | Apr 28, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRNA | Restricted Stock Units | Options Exercise | $0 | -703 | -100% | $0.00* | 0 | Apr 28, 2022 | Common Stock | 703 | $0.00 | Direct | F1, F2 |
transaction | MRNA | Stock Option (Right to Buy) | Award | $0 | +4.06K | $0.00 | 4.06K | Apr 28, 2022 | Common Stock | 4.06K | $142.52 | Direct | F3 | |
transaction | MRNA | Restricted Stock Units | Award | $0 | +670 | $0.00 | 670 | Apr 28, 2022 | Common Stock | 670 | $0.00 | Direct | F4 |
Id | Content |
---|---|
F1 | Restricted stock units convert into common stock on a one-for-one basis. |
F2 | The shares subject to this restricted stock unit award vested in full on April 28, 2022. |
F3 | This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. |
F4 | The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. |